Cargando…
Targeting dendritic cells with TLR-2 ligand–coated nanoparticles loaded with Mycobacterium tuberculosis epitope induce antituberculosis immunity
Novel vaccination strategies are crucial to efficiently control tuberculosis, as proposed by the World Health Organization under its flagship program “End TB Strategy.” However, the emergence of drug-resistant strains of Mycobacterium tuberculosis (Mtb), particularly in those coinfected with HIV-AID...
Autores principales: | Kumar Das, Deepjyoti, Zafar, Mohammad Adeel, Nanda, Sidhanta, Singh, Sanpreet, Lamba, Taruna, Bashir, Hilal, Singh, Pargat, Maurya, Sudeep Kumar, Nadeem, Sajid, Sehrawat, Sharvan, Bhalla, Vijayender, Agrewala, Javed Naim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674924/ https://www.ncbi.nlm.nih.gov/pubmed/36257405 http://dx.doi.org/10.1016/j.jbc.2022.102596 |
Ejemplares similares
-
Fiction and Facts about BCG Imparting Trained Immunity against COVID-19
por: Kaur, Gurpreet, et al.
Publicado: (2022) -
A multiple T cell epitope comprising DNA vaccine boosts the protective efficacy of Bacillus Calmette–Guérin (BCG) against Mycobacterium tuberculosis
por: Maurya, Sudeep Kumar, et al.
Publicado: (2020) -
Cumulative Signaling Through NOD-2 and TLR-4 Eliminates the Mycobacterium Tuberculosis Concealed Inside the Mesenchymal Stem Cells
por: Aqdas, Mohammad, et al.
Publicado: (2021) -
Gut Dysbiosis Thwarts the Efficacy of Vaccine Against Mycobacterium tuberculosis
por: Nadeem, Sajid, et al.
Publicado: (2020) -
Age‐mediated gut microbiota dysbiosis promotes the loss of dendritic cells tolerance
por: Bashir, Hilal, et al.
Publicado: (2023)